Agilon Health (NYSE:AGL) Stock Price Down 4.5% – Time to Sell?

Agilon Health, Inc. (NYSE:AGL) fell 4.5% on Wednesday . The stock traded as low as $81.55 and last traded at $84.2750. 56,045 shares changed hands during mid-day trading, a decline of 85% from the average session volume of 365,220 shares. The stock had previously closed at $88.20.

Analyst Ratings Changes

Several brokerages recently weighed in on AGL. Jefferies Financial Group upgraded shares of Agilon Health from a “hold” rating to a “buy” rating and increased their price objective for the company from $27.50 to $48.00 in a report on Thursday, May 7th. TD Cowen restated a “hold” rating and issued a $55.00 price objective (up from $17.00) on shares of Agilon Health in a report on Monday, May 11th. Wells Fargo & Company restated an “overweight” rating and issued a $72.00 price objective (up from $37.50) on shares of Agilon Health in a report on Friday, May 8th. Citigroup restated a “neutral” rating and issued a $80.00 price objective (up from $18.75) on shares of Agilon Health in a report on Friday, May 15th. Finally, Barclays cut their price objective on shares of Agilon Health from $25.00 to $12.50 and set an “underweight” rating on the stock in a report on Friday, February 27th. Five research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $45.05.

Agilon Health Trading Down 8.6%

The company’s fifty day simple moving average is $28.18 and its two-hundred day simple moving average is $21.07. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.08. The company has a market capitalization of $1.34 billion, a price-to-earnings ratio of -3.73 and a beta of 2.29.

Agilon Health (NYSE:AGL) last posted its earnings results on Wednesday, May 6th. The company reported $1.80 earnings per share for the quarter, topping the consensus estimate of $1.04 by $0.76. The company had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.38 billion. Agilon Health had a negative net margin of 6.09% and a negative return on equity of 146.03%. Research analysts forecast that Agilon Health, Inc. will post -4.17 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Agilon Health

Several large investors have recently made changes to their positions in AGL. Wealthcare Advisory Partners LLC bought a new stake in shares of Agilon Health during the third quarter worth $26,000. LPL Financial LLC increased its position in shares of Agilon Health by 213.4% during the fourth quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock worth $30,000 after acquiring an additional 30,000 shares in the last quarter. Krilogy Financial LLC bought a new stake in shares of Agilon Health during the fourth quarter worth $34,000. CIBC Bancorp USA Inc. bought a new stake in shares of Agilon Health during the third quarter worth $34,000. Finally, Merit Financial Group LLC bought a new stake in shares of Agilon Health during the fourth quarter worth $35,000.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.